Search for a command to run...
Promoter and Institution shareholding in Alembic Pharmaceuticals increased YoY and QoQ, while sector averages remained flat, indicating smart money confidence in the stock despite a stagnant sector.
Public shareholding saw a slight decrease QoQ, suggesting retail investors may be retreating, aligning with a contrarian viewpoint.
In contrast to the best and worst performers in the sector, Alembic's positive changes in Promoter and Institution holdings suggest potential resilience against broader sector trends.
| Category | Trend | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter Holdings | 69.61% | 69.61% | 69.61% | 69.61% | 69.61% | 69.67% | 69.67% | 69.74% | |
2Public Holdings | 11.37% | 10.55% | 10.6% | 10.4% | 10.16% | 9.96% | 9.91% | 9.91% | |
3Foreign Investors | 4.52% | 4.46% | 4.32% | 3.94% | 4.17% | 3.94% | 3.96% | 4.05% | |
4Domestic Investors | 14.5% | 15.38% | 15.47% | 16.05% | 16.06% | 16.43% | 16.46% | 16.3% |